News
BMJ 2022; 377 doi: https://doi.org/10.1136/bmj.o1567 (Published 27 June 2022)Cite this as: BMJ 2022;377:o1567
BMJ 2022; 377 doi: https://doi.org/10.1136/bmj.o1567 (Published 27 June 2022)Cite this as: BMJ 2022;377:o1567
- Jacqui Wise
GPs should be allowed to prescribe medical cannabis as part of a national trial, recommends a review of policy in the legal cannabinoid sector.1
The review by Christopher Hodges, emeritus professor of justice systems at the Centre for Socio-legal Studies at the University of Oxford, calls for a new regulatory framework for the sector to “turbocharge UK cannabinoid innovation.”